At Halozyme, we leverage our drug delivery expertise and proprietary auto-injector technology to support the advancement of innovative medicines that have the potential to change lives. Our mission is to enhance the patient experience by providing treatment options that fit in with the patient’s lifestyle by reducing treatment time and making it easier for some patients to receive treatment at home or closer to home.
Development Services
Halozyme brings extensive experience in subcutaneous drug delivery and auto-injector development, drug-device regulatory approvals, and creating devices tailored to the patients’ needs.
Small-Volume Auto-Injectors (SVAI)
Our diverse portfolio is commercially validated and includes small volume auto-injectors and multi-dose pens for a range of applications.
High-Volume Auto-Injectors (HVAI™)
Our breakthrough HVAI™ is the first clinically demonstrated device capable of delivering 10 mL in under 30 seconds, enabled by our ENHANZE® drug delivery technology.